DVAX’s latest rating updates from top analysts.

In a filing, Dynavax Technologies Corp revealed its 10% Owner Deep Track Biotechnology Maste unloaded Company’s shares for reported $12.08 million on Aug 21 ’25. In the deal valued at $11.03 per share,1,094,994 shares were sold. As a result of this transaction, Deep Track Biotechnology Maste now holds 16,696,492 shares worth roughly $175.31 million.

Then, Deep Track Biotechnology Maste sold 970,143 shares, generating $10,273,814 in total proceeds. Upon selling the shares at $10.59, the 10% Owner now owns 15,726,349 shares.

Before that, Novack David F sold 10,000 shares. Dynavax Technologies Corp shares valued at $140,000 were divested by the President & COO at a price of $14.00 per share. As a result of the transaction, Novack David F now holds 8,078 shares, worth roughly $84819.0.

Goldman downgraded its Dynavax Technologies Corp [DVAX] rating to a Sell from a a Neutral in a research note published on February 11, 2025; the price target was decreased to $12 from $15. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in early February with a ‘”a Neutral”‘ rating. JMP Securities began covering DVAX with “Mkt outperform” recommendation on September 27, 2022.

Price Performance Review of DVAX

On Friday, Dynavax Technologies Corp [NASDAQ:DVAX] saw its stock fall -4.11% to $10.5. Over the last five days, the stock has lost -2.69%. Dynavax Technologies Corp shares have fallen nearly -7.57% since the year began. Nevertheless, the stocks have fallen -17.78% over the past one year. While a 52-week high of $14.63 was reached on 03/07/25, a 52-week low of $9.22 was recorded on 05/14/25.

Levels Of Support And Resistance For DVAX Stock

The 24-hour chart illustrates a support level at 10.33, which if violated will result in even more drops to 10.16. On the upside, there is a resistance level at 10.82. A further resistance level may holdings at 11.15.

How much short interest is there in Dynavax Technologies Corp?

A steep rise in short interest was recorded in Dynavax Technologies Corp stocks on 2025-07-31, dropping by -0.67 million shares to a total of 14.49 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 15.16 million shares. There was a decline of -4.64%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on August 06, 2021 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $19 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.